Lincoln Pharmaceuticals Limited

NSE LINCOLN.NS

Lincoln Pharmaceuticals Limited Price to Earnings Ratio (P/E) on February 06, 2025: 15.13

Lincoln Pharmaceuticals Limited Price to Earnings Ratio (P/E) is 15.13 on February 06, 2025, a -15.52% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Lincoln Pharmaceuticals Limited 52-week high Price to Earnings Ratio (P/E) is 20.23 on December 10, 2024, which is 33.68% above the current Price to Earnings Ratio (P/E).
Lincoln Pharmaceuticals Limited 52-week low Price to Earnings Ratio (P/E) is 11.50 on June 04, 2024, which is -24.00% below the current Price to Earnings Ratio (P/E).
Lincoln Pharmaceuticals Limited average Price to Earnings Ratio (P/E) for the last 52 weeks is 14.88.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

NSE: LINCOLN.NS

Lincoln Pharmaceuticals Limited

CEO	Mr. Mahendrabhai Gulabdas Patel B.A, LLB
IPO Date	Dec. 17, 2015
Location	India
Headquarters	Lincoln House
Employees	1,687
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care

Description

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative. The company also offers branded generics. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.

Key trends

Past 5 years